Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Painreform Ltd

PRFX
Current price
2.58 USD -0.12 USD (-4.44%)
Last closed 2.77 USD
ISIN IL0011651580
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 2 510 853 USD
Yield for 12 month -76.11 %
1Y
3Y
5Y
10Y
15Y
PRFX
21.11.2021 - 28.11.2021

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel. Address: 65 Yigal Alon St., Tel Aviv, Israel, 6744316

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.00 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+86 000 USD

Current Quarter

Last Quarter

Current Year

-15 000 USD

Last Year

+71 000 USD

Current Quarter

-4 000 USD

Last Quarter

-4 000 USD

Key Figures PRFX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -17 809 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -195.07 %
PEG Ratio
Return On Equity TTM -716.67 %
Wall Street Target Price 12.00 USD
Revenue TTM
Book Value -3.53 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -147.36 USD
Diluted Eps TTM -147.36 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PRFX

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History PRFX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:6
Payout Ratio
Last Split Date 09.09.2024

Stock Valuation PRFX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.32
Price Book MRQ 0.63

Financials PRFX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PRFX

For 52 weeks

1.73 USD 80.64 USD
50 Day MA 1.42 USD
Shares Short Prior Month 116 403
200 Day MA 3.77 USD
Short Ratio 0.020
Shares Short 52 326
Short Percent 9.08 %
Dividend information is being updated